APA (7th ed.) Citation

Mayer, I. A., Zhao, F., Arteaga, C. L., Symmans, W. F., Park, B. H., Burnette, B. L., . . . Miller, K. (2021). A randomized phase III post-operative trial of platinum-based chemotherapy (P) versus capecitabine (C) in patients (pts) with residual triple-negative breast cancer (TNBC) following neoadjuvant chemotherapy (NAC): ECOG-ACRIN EA1131. Journal of clinical oncology, 39(15 suppl), 605.

Chicago Style (17th ed.) Citation

Mayer, Ingrid A., et al. "A Randomized Phase III Post-operative Trial of Platinum-based Chemotherapy (P) Versus Capecitabine (C) in Patients (pts) with Residual Triple-negative Breast Cancer (TNBC) Following Neoadjuvant Chemotherapy (NAC): ECOG-ACRIN EA1131." Journal of Clinical Oncology 39, no. 15 suppl (2021): 605.

MLA (8th ed.) Citation

Mayer, Ingrid A., et al. "A Randomized Phase III Post-operative Trial of Platinum-based Chemotherapy (P) Versus Capecitabine (C) in Patients (pts) with Residual Triple-negative Breast Cancer (TNBC) Following Neoadjuvant Chemotherapy (NAC): ECOG-ACRIN EA1131." Journal of Clinical Oncology, vol. 39, no. 15 suppl, 2021, p. 605.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.